Another study identifies the miR-27b/MAIP1 axis as a potential therapeutic target for NAFLD, showing that miR-27b suppresses MAIP1, leading to lipid accumulation in liver cells [97]. The gene discussed is MAIP1; the disease is metabolic dysfunction-associated steatotic liver disease.